The role of oxygen in cutaneous photodynamic therapy

Free Radical Biology and Medicine

Volumn 24, Issue 5, 1998, Pages 835-847

  Fuchs, Jürgen ^a   Thiele, Jens ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Dermatology; Free radicals; Oxygen; Photodynamic therapy; Porphyrins; Singlet oxygen; Skin

Indexed keywords

DEUTERIUM OXIDE; FLUOROCARBON; FREE RADICAL; OXYGEN; PORPHYRIN; SINGLET OXYGEN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; HUMAN; HYPERBARIC OXYGEN; HYPERTHERMIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIMETRY; OXYGEN TENSION; PHOTODYNAMIC THERAPY; PHOTOOXIDATION; PHOTOSENSITIZATION; POLAROGRAPHY; PRIORITY JOURNAL; REVIEW; SAFETY; SIGNAL TRANSDUCTION; SKIN CANCER; ULTRAVIOLET A RADIATION;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; OXYGEN; PHOTOCHEMOTHERAPY; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

ANIMALIA;

EID: 0032520853     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00370-5     Document Type: Review

References (166)

1. Dougherty T. J., Grindey G. B., Fiel R. Photoradiation therapy II. Culture of animal tumors with hematoporphyrin and light. J. Natl. Cancer Inst. 55:1975;155.
2. Lui H., Anderson R. R. Photodynamic therapy in dermatology. Arch. Dermatol. 128:1992;1631-1636.
3. Van Hillegersberg R., Kort W. J., Wilson J. H. P. Current status of photodynamic therapy in oncology. Drugs. 48:1994;510-527.
4. Kennedy J. C., Pottier R. H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B Biol. 98:1992;275-292.
5. Gerlach, H. Ueber das Hautathmen. Arch. Anat. Physiol. Lpz.431-455; 1851.
6. Shaw L. A., Messer A. C. Cutaneous respiration in man. III. The permeability of the skin to carbon dioxide and oxygen as affected by altering their tension in the air surrounding the skin. Am. J. Physiol. 98:1931;93-101.
7. 2 profiles. Ehrly A. M., Hauss J., Huch R. Clinical oxygen pressure measurement. 1987;121-128 Springer, Berlin, Heidelberg, New York.
8. Baumberger J. P., Goodfriend R. B. Determination of arterial oxygen tension in man by equilibration through the intact skin. Fed. Proc. 10:1951;10.
9. Grossmann U., Lübbers D. W. Analysis of epidermal oxygen supply by simulation of oxygen partial pressure fields under varying conditions. Crit. Care Med. 9:1981;734-735.
10. Grossmann U. Simulation of combined transfer of oxygen and heat through the skin using a capillary loop model. Math Biosci. 61:1982;205-236.
11. Spalteholz W. Die Verteilung der Blutgefässe in der Haut. Arch. Anat. Physiol. 10:1983;1-54.
12. Curri S. B. Anatomie microvasculaire de la peau et de ses annexes. Phlebologie. 43:1990;407-430.
13. Roszinski S., Schmeller W. Invasive (intrakutane) und nichtinvasive (transkutane) Messungen des Sauerstoffpartialdrucks der Haut bei Patienten mit chronischer Veneninsuffizienz. Phlebol. 24:1995;1-8.
14. Huch R., Lübbers D. W., Huch A. Quantitative continuous measurement of partial oxygen pressure on the skin of adults and newborn babies. Pflugers Arch. 337:1972;185-198.
15. 2)-method and application in perinatal medicine. J. Perinat. Med. 1:1973;183-191.
16. 2 and their measuring conditions. Birth Defects Orig. Artic. Ser. 15:1979;13-71.
17. 2. Ehrly A. M., Hauss J., Huch R. Clinical oxygen pressure measurement. 1988;3-13 Springer, Berlin.
18. Creutzig A., Dau D., Caspary L., Alexander K. Transcutaneous oxygen pressure measured at two different electrode temperatures in healthy volunteers and patients with arterial occlusive disease. Int. J. Microcirc. Clin. Exp. 5:1987;373-380.
19. Franzeck, U. K. Transkutaner Sauerstoffpatialdruck in der klinischen Mikrozirkulation: Grundlagen, Methoden, Neuentwicklungen von Kombinationssonden und Anwendungen in der Angiologie. Bern: Huber Verlag; 1991.
20. Wienert V. Ist der Einsatz der transkutanen Sauerstoffpartialdruckmessung in der Angiologie sinnvoll? Phlebologie. 21:1992;271-273.
21. Van Duzee B. F. Thermal analysis of human stratum corneum. J. Invest. Dermatol. 65:1975;404-408.
22. Baumgardner J. E., Graves D. J., Neufeld G. R., Quinn J. A. Gas flux through human skin effect of temperature, stripping, and inspired tension . J. Appl. Physiol. 58:1985;1536-1545.
23. 2 measurement in dermatology. Acta Derm. Venereol. Suppl. 185:1994;21-25.
24. 2) in peripheral arterial occlusive disease (a review of the methodological and clinical literature with a special reference to critical limb ischemia). Vasa. 21:1992;111-126.
25. Ubbink D. T., Jacobs M. J. H., Tangelder G. J., Slaaf D. W., Reneman R. S. The usefulness of capillary microscopy, transcutaneous oximetry and laser Doppler fluxmetry in the assessment of the severtity of lower limb ischaemia. Int. J. Microcirc. Clin. Exp. 14:1994;34-44.
26. Franzeck U. K., Huch A., Zimmerman A. R., Leu A. J., Huch R., Hoffmann U., Bollinger A. A triple electrode for simultaneous investigations of transcutaneous oxygen tension, laser Doppler flowmetry and dynamic fluorescence video microscopy. Int. J. Microcirc. Clin. Exp. 14:1994;269-273.
27. Roszinski S., Köser T., Wilhelm K. P., Schmeller W. Untersuchungen der Oxygenierung von Dermis und Subcutis bei Dermatoliposklerose. Vasa. 22:1993;297-305.
28. Bicher, H. I.; Hetzel, F. W.; Vaupel, P.; Sandhu, T. S. Microcirculation modifications by localized microwave hyperthermia and hematoporphyrin phototherapy. Proc. 11th Eur. Conf. Microcirculation. Biblthca. Anat. 20:628-632; 1981.
29. Hetzel F. W., Farmer H. Dose effect relationships in a mouse mammary tumor. Doiron D. R., Gomer C. J. Porphyria localization and treatment of tumors. 1984;583-590 Liss, New York.
30. Reed M. W., Mullins A. P., Anderson G. L. The effect of photodynamic therapy on tumor oxygenation. Surgery. 106:1989;94-99.
31. Tromberg B. J., Kimel S., Orenstein A., Barker S. J., Hyatt J., Nelson J. S., Roberts W. G., Berns M. W. Tumor oxygen tension during photodynamic therapy. J. Photochem. Photobiol. B Biol. 5:1990;121-126.
32. Tromberg B. J., Orenstein A., Kimel S., Barker S. J., Hyatt J., Nelson J. S., Berns M. W. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol. 52:1990;375-386.
33. Liu K. J., Gast P., Moussavi M., Norby S. W., Vahidi N., Walczak T., Wu M., Swartz H. M. Lithum phtalocyanine A probe for electron paramagnetic resonance oximetry in viable biological systems . Proc. Natl. Acad. Sci. USA. 90:1993;5438-5442.
34. Zweier J. L., Chzhan M., Ewert U., Schneider G., Kuppusamy P. Development of a highly sensitive probe for measuring oxygen in biological tissue. J. Magn. Res., Series B. 105:1994;52-57.
35. 2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low frequency electron paramagnetic resonance oximetry. Radiat. Res. 145:1996;610-618.
36. Vink R. Nuclear magnetic resonance spectroscopy and the study of tissue oxygen metabolism A review . Adv. Exp. Med. Biol. 316:1992;187-193.
37. Mc Goron A. J., Pratt R., Zhang J., Shiferwa Y., Thomas S., Millard R. Perfluorocarbon distribution to liver, lung and spleen of emulsions of perfluorotributylamine (FTBA) in pigs and rats and perfluorooctyl bromide (PFOB) in rats and dogs by 19F NMR spectroscopy. Art. Cells Blood Subst. Immob. Techn. 22:1994;1243-1250.
38. 2 imaging in vivo with perfluorocarbon F-19 NMR tracking oxygen from the airway through the blood to organ tissues . Art. Cells Blood Subst. Immob. Techn. 22:1994;1029-1042.
39. Mason R. P. Non-invasive physiology 19F NMR of perfluorocarbons . Art. Cells Blood Subst. Immob. Techn. 22:1994;1141-1153.
40. Mason R. P., Antich P. P., Babcock E. E., Constantinescu A., Peschke P., Hahn E. W. Non invasive determination of tumor oxygen tension and local variation with growth. Int. J. Radiat. Oncol. Biol. Phys. 29:1995;95-103.
41. Vanderkooi J. M., Maniara G., Green T. J., Wilson D. F. An optical method for measurement of dioxygen concentration based upon quenching of phosphorescence. J. Biol. Chem. 262:1987;5476-5482.
42. Stücker M., Schulze L., Ziemann R., Köster T., Hoffmann K., Altmeyer P., Lübbers D. W. Aufnahme atmosphärischen Sauerstoffs durch die Haut als Mass für die epidermale Sauerstoffversorgung. Hautarzt. 48:(Suppl):1997;S118.
43. Bambot S. B., Rao G., Romauld M., Carter G. M., Sipior J., Terpetchnig E., Lakowicz J. R. Sensing oxygen through skin using a red diode laser and fluorescence lifetimes. Biosensors & Bioelectronics. 10:1995;643-652.
44. Caspary L., Thum J., Creutzig A., Lübbers D. W., Alexander K. Quantitative reflection spectrophotometry spatial and temporal variation of Hb oxygenation in human skin . Int. J. Microcirc. Clin. Exp. 15:1995;131-136.
45. Merschbrock U., Hoffmann J., Caspary L., Huber J., Schmickaly U., Lübbers D. W. Fast wavelength scanning reflectance spectrophotometer for noninvasive determination of hemoglobin oxygenation in human skin. Int. J. Microcirc. Clin. Exp. 14:1994;274-281.
46. Tyrrell R. M., Pidoux M. Singlet oxygen involvement in the inactivation of cultured human skin fibroblasts by UVA (334 nm, 365 nm) and near visible (405 nm) radiation. Photochem. Photobiol. 49:1989;407-412.
47. Sato K., Taguchi H., Maeda T., Minami H., Asada Y., Watanabe Y., Yoshikawa K. The primary cytotoxicity in ultraviolet-A-irradiated riboflavin solution is derived from hydrogen peroxide. J. Invest. Dermatol. 105:1995;608-612.
48. Basu-Modak S., Tyrrell R. M. Singlet oxygen A primary effector in the UVA/near visible light induction of the human heme oxygenase gene . Cancer Res. 53:1993;4505-4510.
49. Vile G. F., Tyrrell R. M. UVA radiation induced oxidative damage to lipids and proteins in vitro and in human skin fibroblasts is dependent on iron and singlet oxygen. Free Radic. Biol. Med. 18:1995;721-730.
50. Grether-Beck S., Olaizola-Horn S., Schmitt H., Grewe M., Jahnke A., Johnson J. P., Briviba K., Sies H., Krutman J. Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc. Natl. Acad. Sci. USA. 93:1996;14586-14591.
51. Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem. Photobiol. 55:1992;145-157.
52. Nitzan Y., Wexler H. M., Finegold S. M. Inactivation of anaerobic bacteria by various photosensitized porphyrins or by hemin. Current Microbiology. 29:1994;125-131.
53. Monteiro H. P., Abdalla D. S. P., Augusto O., Bechara E. J. H. Free radical generation during delta-aminolevulinic acid autoxidation Induction by hemoglobin and connections with porphyrinpathies . Arch. Biochem. Biophys. 271:1989;206-216.
54. Demasi M., Costa C. A., Pascual C., Llesuy S., Bechara E. J. H. Oxidative tissue response promoted by 5-aminolevulinic acid promptly induces the increase of plasma antioxidant capacity. Free Radic. Res. 26:1997;235-243.
55. Lee S. K., Forbes I. J., Betts W. H. Oxygen dependency of photocytotoxicity with hemtoporphyrin derivative. Photochem. Photobiol. 39:1984;631-634.
56. Gomer C. J., Razum N. J. Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions. Photochem. Photobiol. 40:1984;435-439.
57. Mitchell J. B., McPherson S., DeGraff W. Oxygen dependence of hematoporphyrin derivative induced photoinactivation of Chinese hamster cells. Cancer Res. 45:1985;2008-2011.
58. Moan J., Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK-3025 cells. Cancer Res. 45:1985;1608-1610.
59. Henderson B. W., Fingar V. H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47:1987;3110-3114.
60. Chapman J. D., Stobbe C. C., Arnfield M. R. Oxygen dependency of tumor cell killing in vitro by light activated Photofrin II. Radiat. Res. 126:1991;73-79.
61. Henderson B. W., Waldow S. M., Mang T. S., Potter W. R., Dougherty T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 45:1985;572-576.
62. Star W. M., Marijnissen H. P. A., van den Berg-Blok A. E., Versteeg J. A. C., Franken K. A. P., Reinhold H. S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46:1986;2532-2540.
63. Chen Q., Chen H., Hetzel F. W. Tumor oxygenation changes post photodynamic therapy. Photochem. Photobiol. 63:1996;128-131.
64. Giri U., Sharma S. D., Abdulla M., Athar M. Evidence that in situ generated oxygen species act as potent stage I tumor promotor in mouse skin. Biochem. Biophys. Res. Commun. 209:1995;698-705.
65. Giri U., Iqbal M., Athar M. Porphyrin mediated photosensitization has a weak tumor promoting activity in mouse skin Possible role of in-situ generated reactive oxygen species . Carcinogenesis. 17:1996;2023-2028.
66. Fiedler D. M., Eckl P. M., Krammer B. Does alpha-aminolaevulinic acid induce genotoxic effects? J. Photochem. Photobiol. B. 33:1996;39-44.
67. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 36:1976;2326-2329.
68. Ito T. Cellular and subcellular mechanisms of photodynamic action The 102 hypothesis as a driving force in recent research . Photochem. Photobiol. 28:1978;493-508.
69. Athar M., Mukhtar H., Bickers D. R. Differential role of reactive oxygen intermediates in photofrin-I-mediated and photofrin-II-mediated photoenhancement of lipid peroxidation in epidermal microsomal membranes. J. Invest. Dermatol. 90:1988;652-657.
70. Valenzo D. P. Photomodification of biological membranes with emphasis on singlet oxygen mechanisms. Photochem. Photobiol. 46:1987;147-160.
71. Pathak M. A., Carraro C. Reactive oxygen species in cutaneous photosensitivity reactions in porphyrias and PUVA photochemotherapy and in melanin pigmentation. Hayaishi O., Imamura S., Miyachi Y. The biological role of reactive oxygen species in skin. 1987;75-94 Elsevier, New York.
72. Cilento G., Adam W. Photochemistry and photobiology without light. Photochem. Photobiol. 48:1988;361-368.
73. Cilento G., Adam W. From free radicals to electronically excited species. Free Radic. Biol. Med. 19:1995;103-114.
74. Corey E. J., Mehrotra M. M., Khan A. U. Water induced dismutation of superoxide anion generates singlet molecular oxygen. Biochem. Biophys. Res. Commun. 145:1987;842-846.
75. Moan J. On the diffusion length of singlet oxygen in cells and tissues. J. Photochem. Photobiol. B Biol. 6:1990;343-344.
76. Cadenas E., Sies H. Low-level chemiluminescence as an indicator of singlet molecular oxygen in biological systems. Methods Enzymol. 105:1984;221-231.
77. Murphy M. E., Sies H. Visible-range low-level chemiluminescence in biological systems. Methods Enzymol. 186:1990;595-610.
78. Roldan E. J. A., Pinus C. R., Turrens J. F., Boveris A. Chemiluminescence of ischemic and reperfused intestine in vivo. Gut. 30:1989;184-187.
79. Costa L. E., Llesuy S., Boveris A. Active oxygen species in the liver of rats submitted to chronic hypobaric hypoxia. Am. J. Physiol. 264:1993;C1395-C1400.
80. Nye A. C., Rosen G. M., Gabrielson E. W., Keana J. F. W., Prabhu V. S. Diffusion of singlet oxygen into bronchial epithelial cells. Biochim. Biophys. Acta. 928:1987;1-7.
81. Fuchs J., Groth N., Herrling T., Packer L. In vivo EPR skin imaging. Methods Enzymol. 203:1994;140-149.
82. Herrling T. E., Groth N., Fuchs J. Biochemical EPR imaging of skin. Applied Magnetic Resonance. 11:1996;471-486.
83. Monteiro H. P., Stern A. Redox modulation of tyrosin phosphorylation dependent signal transduction pathways. Free Radic. Biol. Med. 21:1996;323-333.
84. Sun Y., Oberley L. W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:1996;335-348.
85. Fanburg B. L., Massaro D. J., Cerutti P. A., Gail D. B., Berberich M. A. Regulation of gene expression by oxygen tension. Am. J. Physiol. 262:1992;L235-L241.
86. Horrowitz S., Dafni N., Shapiro D. L., Holm B. A., Notter R. H., Quible D. J. Hyperoxic exposure alters gene expression in the lung. J. Biol. Chem. 264:1989;7092-7095.
87. Helfman T., Falanga V. Gene expression in low oxygen tension. Am. J. Med. Sci. 306:1993;37-41.
88. Luna M. C., Wong S., Gomer C. J. Photodynamic therapy mediated induction of early response genes. Cancer Res. 54:1994;1374-1380.
89. Kick G., Messer G., Plewig G., Kind P., Goetz A. E. Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy. Br. J. Cancer. 74:1996;30-36.
90. Pass H. I. Photodynamic therapy in oncology mechanisms and clinical use . J. Natl. Cancer Inst. 85:1993;443-456.
91. Flohe L., Brigelius-Flohe R., Saliou C., Traber M. G., Packer L. Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 22:1997;1115-1126.
92. Kick G., Messer G., Goetz A., Weiss E. H., Kind P., Plewig G. Transcriptional activation of the c-jun protooncogene - But no induction of AP-1 DNA binding by photodynamic therapy. J. Invest. Dermatol. 101:1993;465A.
93. Gomer C. J., Ryter S. W., Ferrario A., Rucker N., Wong S., Fischer A. M. R. Photodynamic therapy mediated oxidative stress can induce expressions of heat shock proteins. Cancer Res. 56:1996;2355-2360.
94. Holthusen H. Beiträge zur Biologie der Strahlenwirkung. Pflugers Arch. Ges. Physiol. 187:1921;1-24.
95. Gans O. Über die Gewebsatmung in der gesunden und kranken Haut. Dtsch Med. Wochschr. 49:1923;16.
96. Gray L. H., Conger A. D., Ebert M., Hornsey S., Scott O. C. A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26:1953;638-648.
97. Hewitt H. B., Wilson C. W. The effect of tissue oxygen tension on the radiosensitivity of leukaemia cells irradiated in situ in the livers of leukaemic mice. Br. J. Cancer. 13:1959;675-684.
98. Baxendale J. H. Effects of oxygen and pH in radiation chemistry of aqueous solutions. Radiat. Res. 4:(Suppl):1964;114-138.
99. Cerutti P. A. Effects of ionizing radiation on mammalian cells. Naturwissenschaften. 61:1974;51-59.
100. Moulder J. E., Rockwell S. Tumor hypoxia Its impact on cancer therapy . Cancer Metastasis Rev. 5:1987;313-341.
101. Rockwell S., Mate T. P., Irvine C. G., Nierenburg M. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1315-1318.
102. Hendry J. H. Quantification of the radiotherapeutic importance of naturally hypoxic normal tissues from collated experiments with rodents using single doses. Int. J. Radiat. Oncol. Biol. Phys. 5:1979;971-976.
103. Rockwell S., Irvin C. G., Kelley M., Hughes C. S., Yabuki H., Porter E., Fischer J. J. Effects of hyperbaric oxygen and a perfluorooctylbromide emulsion on the radiation responses of tumors and normal tissues in rodents. Int. J. Radiat. Oncol. Biol. Phys. 22:1991;87-93.
104. Malkinson F. D., Keane J. T. Radiobiology of the skin. Goldsmith L. A. Biochemistry and physiology of the skin. 1983;769-814 Oxford University Press, New York.
105. Strelkoy R. B., Chizhov A., Tokarey O., Tolstykh V. N., Kucherenko N. G. Radioprotective action of a gas hypoxic mixture GHM-10 in multiple irradiations of rat and human skin (in Russian). Radiobiologiia. 23:1983;358-362.
106. Dupuis N. P., Kusumoto T., Robinson M. F., Liu F., Menon K., Teicher B. A. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion-carbogen breathing. Art. Cells Blood Subst. Immob. Techn. 23:1995;423-429.
107. Teicher B. A., Holden S. A., Ara G., Ha C. S., Herman T. S., Northey D. C. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents. J. Cancer Res. Clin. Oncol. 118:1992;509-514.
108. Kapp D. S. From laboratory studies to clinical trials Past benefits and further directions in hyperthermia . Int. J. Hyperthermia. 10:1994;355-359.
109. Yoshikawa T., Kokura S., Tainaka K., Itani K., Oyamada H., Kaneko T., Naito Y., Kondo M. The role of active oxygen species and lipid peroxidation in the antitumor effect of hyperthermia. Cancer Res. 53:(Suppl. 10):1993;2326-2329.
110. Song C. W., Chelstrom L. M., Haumschild D. J. Changes in human skin blood flow by hyperthermia. Int. J. Radiat. Oncol. Biol. Phys. 18:1990;903-907.
111. Song C. W., Shakil A., Osborn J. L., Iwata K. Tumor oxygenation is increased by hyperthermia at mild temperatures. Int. J. Hyperthermia. 12:1996;367-373.
112. 2 can be increased markedly by mild hyperthermia. Br. J. Cancer. 74:(Suppl. 27):1996;S217-S221.
113. 2 and cell survival in tumors. Cancer Res. 53:1993;2076-2080.
114. 2 and pH response of mammary carcinoma to hyperthermia Dependence of transplant site and duration of treatment . Radiat. Res. 132:1992;152-156.
115. Hetzel F. W., Chen H., Chen Q. Tumor response and oxygenation after combined PDT and hyperthermia. Int. J. Radiat. Oncol. Biol. Phys. 30:(Suppl. 1):1994;312.
116. Gottfried V., Kimel S. Temperature effects on photosensitized processes. J. Photochem. Photobiol. B Biol. 8:1991;419-430.
117. Chen Q., Chen H., Shapiro H., Hetzel F. W. Sequencing of combined hyperthermia and photodynamic therapy. Radiat. Res. 146:1996;293-297.
118. Svaasand L. O. Thermal and optical dosimetry for photoradiation therapy and malignant tumors. Andreoni A., Cubeddu R. Porphyrins in tumor phototherapy. 1984;261-279 Plenum Press, New York.
119. Colin D., Saumet J. L. Influence of external pressure on transcutaneous oxygen tension and laser Doppler flowmetry on sacral skin. Clin. Physiol. 16:1996;61-72.
120. Foster T. H., Murant R. S., Bryant R. G., Knox R. S., Gibson S. L., Hilf R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126:1991;296-303.
121. Foster T. H., Gao L. Dosimetry in photodynamic therapy Oxygen and the critical importance of capillary density . Radiat. Res. 130:1992;379-383.
122. Mang T. S., Dougherty T. J., Potter W. R. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem. Photobiol. 45:1987;501-506.
123. Boyle D. G., Potter W. R. Photobleaching of photofrin II as a means of eliminating skin photosensitivity. Photochem. Photobiol. 46:1987;997-1001.
124. Messmann H., Mlkvy P., Buonaccorsi G., Davies C. L., Mac Robert A. J., Bown S. G. Enhancement of photodynamic therapy with 5-aminolaevulinic acid induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br. J. Cancer. 72:1995;589-594.
125. Ogilby P. R., Foote C. S. Singlet molecular oxygen luminescence in solution following pulsed laser excitation. Solvent deuterium isotope effects on the life time of singlet oxygen. J. Am. Chem. Soc. 104:1982;2069-2070.
126. Okumura M., Sugibayashi K., Ogawa K., Morimoto Y. Skin permeability of water soluble drugs. Chem. Pharm. Bull. 37:1989;1404-1406.
127. Laissue J. A., Altermatt H. J., Bally E., Gebbers J. O. Protection of mice from whole body irradiation by deuteration of drinking water Hematologic findings . Exp. Hematol. 15:1987;177-180.
128. Fielden E. M., Hart E. J. Primary radical yields and some rate constants in heavy water. Radiat. Res. 33:1968;426-436.
129. Merkel P. B., Nilsson R., Kearns D. R. Deuterium effects on singlet oxygen lifetimes in solution A new test of singlet oxygen reactions . J. Am. Chem. Soc. 84:1972;1030-1031.
130. Altermatt H. J., Gebbers J. O., Laissue J. A. Heavy water enhances the anti-neoplastic effects of 5-fluoro-uracil and bleomycin in nude mice bearing human carcinoma. Int. J. Cancer. 45:1990;475-480.
131. Laissue J. A., Stoner R. D. Deuterium isotope effects on lymphoid tissues and humoral antibody response in mice. Virchows Arch. Pathol. Anat. Histopathol. 383:1979;149-166.
132. Evans N. T. S., Naylor P. F. D. Steady states of oxygen tension in human dermis. Respir. Physiol. 2:1966;46-60.
133. Rudolph R., Tripuraneni P., Koziol J. A., McKean-Matthews M., Frutos A. Normal transcutaneous oxygen pressure in skin after radiation therapy for cancer. Cancer. 74:1994;3063-3070.
134. Fischer S. M., Jain K. K., Braun E., Lehr S. Handbook of hyperbaric oxygen therapy. 1988;Springer, Berlin.
135. Jirsa M. Jr, Sip M., Jirsa M. Influence of hyperbaric oxygenation on bilirubin and ditaurobilirubin auto-oxidation and porphyrin-sensitized photo-oxidation. J. Photochem. Photobiol. B Biol. 5:1990;295-302.
136. Jirsa M. Jr, Pouckova P., Dolezal J., Pospisil J., Jirsa M. Hyperbaric oxygen and photodynamic therapy in tumor bearing nude mice. Eur. J. Cancer. 27:1991;109.
137. Dong G. C., Hu S. X., Zhao G. Y., Gao S. Z., Wu L. R. Experimental study on cytotoxic effects of hyperbaric oxygen and photodynamic therapy on mouse transplanted tumor. Chinese Med. J. 100:1987;697-702.
138. Roberts D. J. H., Cairnduff F., Dixon B., Brown S. B. Modulation of the response of a rodent fibrosarcoma to photodynamic therapy by hyperbaric oxygen treatment. Oncology Reports. 2:1995;387-390.
139. Wilhelm E., Battino R. Thermodynamic functions of the solubilities of gases in liquids at 25°C. Chem. Rev. 73:1977;1-9.
140. Lane T. A. Perfluorochemical based artificial oxygen carrying red cell substitutes. Transfus. Sci. 16:1995;19-31.
141. Faithfull N. S. Oxygen delivery from fluorocarbon emulsions - Aspects of convective and diffusive transport. Chang T. M. S. Blood substitutes and oxygen carriers. 1993;569-579 Marcel Dekker Inc, New York.
142. Clark L. C., Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 152:1966;1755-1756.
143. Millard R. W. Oxygen solubility, rheology and hemodynamics of perfluorocarbon emulsion blood substitutes. Art. Cells Blood Subst. Immob. Techn. 22:1994;235-244.
144. Riess J. G., Le Blanc M. Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications. Pure Appl. Chem. 54:1982;2383-2392.
145. Riess J. G. Fluorocarbon based in vivo oxygen transport and delivery systems. Vox Sang. 61:1991;225-239.
146. Dracker R. A. The development and use of oxygen carrying blood substitutes. Immunol. Invest. 24:1995;403-410.
147. Glogar D. H., Kloner R. A., Muller J., DeBoer L., Braunwald E., Clark L. C. Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science. 211:1981;1439-1441.
148. Tremper K. K., Friedman A. E., Levine E. M., Lapin R., Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen transport fluid. Fluosol DA. New Engl. J. Med. 307:1982;277-283.
149. Ricci J. L., Sloviter H. A., Ziegler M. M. Intestinal ischemia reduction of mortality utilizing intraluminal perfluorochemical . Am. J. Surg. 149:1985;84-90.
150. Forman M. B., Perry J. M., Wilson B. H., Verani M. S., Kaplan P. R., Showl F. A., Friesinger G. C. Demonstration of myocardial reperfusion injury in humans Result of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction . J. Am. Coll. Cardiol. 18:1991;911-918.
151. Ramasastry S. S., Waterman P., Angel M. F., Futrell J. W. Effect of Fluosol-DA (20%) on skin flap survival in rats. Ann. Plast. Surg. 15:1985;436-442.
152. Chowdary R. P., Berkower A. S., Moss M. L., Hugo N. E. Fluorocarbon enhancement of skin flap survival in rats. Plast. Reconstr. Surg. 79:1987;98-101.
153. Yessenow R. S., Maves M. D. Effects of Oxypherol-ET on random skin-flap survival in the swine model. Arch. Otolaryngo. Head Neck Surg. 114:1988;973-976.
154. Martin D. F., Porter E. A., Fischer J. J., Rockwell S. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas. Radiat. Res. 112:1987;45-51.
155. Lee I., Levitt S. H., Song C. W. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and the skin of A/J mice. Radiat. Res. 112:1987;173-182.
156. Teicher B. A., Holden S. A. Survey of the effect of adding Fluosol DA 20%/oxygen to treatment with various chemotherapeutic agents. Cancer Treatment Rep. 71:1987;173-182.
157. Rose C., Lustig R., McIntosh N., Teicher B. A clinical trial of fluosol-DA 20% in advanced squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1325-1330.
158. Lustig R., Rose C. M., McIntosh-Lowe N. L. Fluosol-DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma. Biomat. Art. Cells Art. Org. 16:1988;511-518.
159. 2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen. Cancer Res. 47:1987;442-446.
160. Yoshimura Y., Nakajima T., Kami T. Fluorocarbon (FC-43) in augmentation of tissue oxygen and its experimental use for flap survival. Ann. Plast. Surg. 16:1986;111-115.
161. Flaim S. F. Pharmacokinetics and side effects of perfluorocarbon based blood substitutes. Art. Cells Blood Subst. Immob. Techn. 22:1994;1043-1054.
162. Iwai T., Sato S., Yamada T., Muraoka Y., Sakurazawa K., Inoue Y., Kinoshita H., Endo M. A new treatment for ischemic ulcers Foot bath therapy using high oxygen soluble fluid . J. Cardiovasc. Surg. 30:1989;490-493.
163. Oxynoid O. E., Sydliarov D. P., Aprosin Y. D., Obratsov V. V. Application of fluorocarbon emulsions as components of cosmetics and medical ointments. Art. Cells Blood Subst. Immob. Techn. 22:1994;1331-1336.
164. Chowdhary R. P., Cundall R. B., Morgan C. G. Influence of fluorocarbon emulsions on porphyrin-sensitised oxidation of histidine. Photochem. Photobiol. 51:1990;395-400.
165. Fingar V. H., Mang T. S., Henderson B. W. Modification of photodynamic therapy induced hypoxia by Fluosol-DA (20%) and carbogen breathing in mice. Cancer Res. 48:1988;3350-3359.
166. Berenbaum M. C., Akande S. L., Armstrong F. H., Bentley P. K., Bonnett R., White R. D., Lowe K. C. Perfluorochemicals and photodynamic therapy in mice. Piiper J. Oxygen transport to Tissue XII. 1990;277-282 Plenum Press, New York.